000			01870 a2200469 4500
005			20250515204459.0
264		0	_c20100607
008			201006s 0 0 spa d
022			_a0213-005X
024	7		_a10.1016/S0213-005X(09)73214-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aGarcés, Piedad Arazo
245	0	0	_a[Etravirine in first-line therapy]. _h[electronic resource]
260			_bEnfermedades infecciosas y microbiologia clinica _cDec 2009
300			_a12-20 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnti-HIV Agents _xadministration & dosage
650	0	4	_aChemical and Drug Induced Liver Injury _xetiology
650	0	4	_aDrug Eruptions _xetiology
650	0	4	_aDrug Interactions
650	0	4	_aDrug Resistance, Multiple, Viral
650	0	4	_aGenes, pol _xgenetics
650	0	4	_aHIV Infections _xcomplications
650	0	4	_aHIV Reverse Transcriptase _xantagonists & inhibitors
650	0	4	_aHIV-1 _xdrug effects
650	0	4	_aHepatitis, Viral, Human _xcomplications
650	0	4	_aHeroin Dependence _xcomplications
650	0	4	_aHumans
650	0	4	_aMental Disorders _xchemically induced
650	0	4	_aMethadone _xpharmacokinetics
650	0	4	_aMulticenter Studies as Topic _xstatistics & numerical data
650	0	4	_aNitriles
650	0	4	_aPatient Compliance
650	0	4	_aPyridazines _xadministration & dosage
650	0	4	_aPyrimidines
650	0	4	_aRandomized Controlled Trials as Topic _xstatistics & numerical data
650	0	4	_aReverse Transcriptase Inhibitors _xadministration & dosage
650	0	4	_aSubstance Abuse, Intravenous _xcomplications
700	1		_aTena, Esther Valero
773	0		_tEnfermedades infecciosas y microbiologia clinica _gvol. 27 Suppl 2 _gp. 12-20
856	4	0	_uhttps://doi.org/10.1016/S0213-005X(09)73214-8 _zAvailable from publisher's website
999			_c19489316 _d19489316